Honing in on the (epi)genetic basis of AITL

Abstract

In this issue of Blood, Odejide et al report on recurring mutations in a large series of patients with angioimmunoblastic T-cell lymphoma (AITL) clustering around three epigenetic modifiers: TET2 , DNMT3, and IDH2. © 2014 by The American Society of Hematology.